| 中文名称 | 3 - ((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶- |
|---|
| 中文同义词 | 3 - ((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-;托法替尼杂质30;3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-1-基)-3-氧代丙酸乙酯;托法替尼杂质122;托法替尼杂质328;3-{4-甲基-3-[甲基-(7H-吡咯[2,3-D]嘧啶-4-基)-氨基]-哌啶-1-基]-3-氧代丙酸乙酯(托法替尼杂质K);乙基3-((3R,4R)-4-甲基-3-(甲基(7H吡咯[2,3-D]嘧啶-4-基)氨基)哌啶-1-基)-3-氧丙酸酯;3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-1-基)-3-氧代丙酸乙酯(托法替布杂质) |
|---|
| 英文名称 | 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- |
|---|
| 英文同义词 | 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-;ethyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d] pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate;Tofacitinib impurity 23/ethyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d] pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate;Tofacitinib-29;2-Descyano-2-ethyl Formyl-tofacitinib;Azilsartan medoxomil impurity328;Ethyl 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropa;3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionic acid ethyl ester |
|---|
| CAS号 | 1675248-18-6 |
|---|
| 分子式 | C18H25N5O3 |
|---|
| 分子量 | 359.43 |
|---|
| EINECS号 | |
|---|
| 相关类别 | 托法替尼杂质;杂质对照品 |
|---|
| Mol文件 | 1675248-18-6.mol |
|---|
| 结构式 | ![3 - ((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶- 结构式](CAS/20211123/GIF/1675248-18-6.gif) |
|---|
